James T. Borello RIA’s Catalyst Pharmaceutical CPRX Stock Holding History

James T. Borello RIA’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-4	Closed	-$126	–	1289
2026 Q2	$126	Hold	4	–	–	﹤0.01%	1173
2026 Q1	$99	Hold	4	–	–	﹤0.01%	1165
2025 Q4	$93	Buy	+4	New	+$89	﹤0.01%	1089

Other funds holding CPRX

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

James T. Borello RIA's CPRX Position: Q3 2026 in Review

James T. Borello RIA sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 4 shares — an estimated $126 sold.

James T. Borello RIA first reported a position in CPRX in Q4 2025 and held it in 3 quarters. The position peaked at $126 in Q2 2026. 1 fund tracked by Wall St. Rank holds CPRX as of Q3 2026.

James T. Borello RIA reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
James T. Borello RIA sold 4 Catalyst Pharmaceutical shares in Q3 2026, an estimated $126.
James T. Borello RIA first reported a position in Catalyst Pharmaceutical in Q4 2025 and held it in 3 quarters.
James T. Borello RIA's Catalyst Pharmaceutical position peaked at $126 in Q2 2026.
1 fund tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.